# A Study on the Efficacy of Atezolizumab Combined with Chemotherapy

> **NCT06780826** · — · RECRUITING · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 1430 (estimated)

## Conditions studied

- Lung Cancer, Small Cell

## Interventions

- **DRUG:** Atezolizumab
- **DRUG:** Etoposide
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT06780826
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-28
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 1430 (ESTIMATED)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06780826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06780826, "A Study on the Efficacy of Atezolizumab Combined with Chemotherapy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06780826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*